Doug Sposetta
Family · Austintown, OHNPI 1598131237
Payments from drug & device makers
Across 1,134 payments — averaging $15.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Novo Nordisk$2K
- Pfizer$1K
- AstraZeneca$1K
- Lilly USA, LLC$1K
- Amgen$1K
- plus $8K from 44 others
What the payments were for
- Food & beverage$17,03698%
- Education$3152%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$17,351 in reported general payments places this provider in the 95th percentile of 6,812 family providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 141 | $109,651 |
| OzempicSemaglutide | 82 | $81,432 |
| MounjaroTirzepatide | 68 | $79,675 |
| JardianceEmpagliflozin | 38 | $46,314 |
| FarxigaDapagliflozin Propanediol | 41 | $39,587 |
| TrulicityDulaglutide | 32 | $37,657 |
| UbrelvyUbrogepant | 28 | $31,827 |
| Nurtec OdtRimegepant Sulfate | 28 | $27,065 |
| GlyxambiEmpagliflozin/Linagliptin | 29 | $23,542 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 27 | $21,365 |
| TrintellixVortioxetine Hydrobromide | 18 | $21,137 |
| JanuviaSitagliptin Phosphate | 21 | $19,223 |
| XareltoRivaroxaban | 22 | $18,262 |
| VascepaIcosapent Ethyl | 36 | $18,127 |
| Breo ElliptaFluticasone/Vilanterol | 33 | $14,842 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis, Nurtec Odt | $1,367 | $136,716169 claims |
| Lilly USA, LLCMounjaro, Trulicity | $1,302 | $117,332100 claims |
| Boehringer IngelheimJardiance, Glyxambi, Spiriva Respimat, Tradjenta | $785 | $91,554121 claims |
| Novo NordiskOzempic | $1,540 | $81,43282 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Brilinta, Symbicort | $1,343 | $62,117102 claims |
| AbbVieUbrelvy, Linzess | $2,223 | $45,09652 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $452 | $36,20760 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $247 | $21,13718 claims |
| MerckJanuvia | $516 | $19,22321 claims |
| Johnson & JohnsonXarelto | $427 | $18,26222 claims |
| Astellas Pharma US IncMyrbetriq | $460 | $12,82914 claims |
| Axsome Therapeutics, Inc.Auvelity | $124 | $6,00311 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,812 family providers in Ohio.
Other family in Austintown
- Eileen FauldsLewis Center$991K
- Leigh Ann PanschDayton$670K
- Natalie BelliniMayfield Heights$582K
- Kaitlyn LovettMontgomery$286K
- Amy RossDayton$281K
- Renee OttSandusky$179K
- Megan MillerSpringfield$156K
- George KnightCincinnati$130K
- Jillian HuntCincinnati$116K
- Florence StewartNew Albany$113K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.